AskBio Inc. · 5 hours ago
VP, GDNF Clinical Development
AskBio Inc. is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The Vice President of GDNF Clinical Development will be responsible for developing and implementing clinical development strategies, overseeing global clinical programs, and leading a team of medical directors to ensure successful regulatory approvals and commercial launches.
BiopharmaBiotechnologyHealth CareManufacturingMedicalMedical Device
Responsibilities
Lead the global strategic clinical development initiatives for AskBio’s GDNF IPT, fostering cross-functional alignment via open and collaborative discussions
Lead, manage, and mentor a team of clinical development physicians
Contribute to budget planning and budget management related to clinical development activities aligned with the IPT goals
Provide clinical development input and maintain alignment with the CNS Drug Delivery IPT and GDNF IPT development plans
Contribute to development and execution of the clinical strategy across GDNF and other CNS programs, ensuring that the overall scientific and medical content of each clinical study is scientifically rigorous, cost-effective sound and designed for success
Proactively work to identify clinical risks and implement risk mitigation strategies for complex gene therapy studies
Provide input to CDP development, in line with the Target Product Profile (TPP), for successful global regulatory approvals and market access
Partner cross-functional colleagues (including Clinical Operations, Medical Affairs, Pharmacovigiliance, Regulatory, Commercial, Nonclinical, Drug Delivery and CMC) to design, execute and report clinical trials
Partner with Clinical Operations to co-chair the IPT CST to oversee, execute and deliver the end-to-end clinical development strategy in alignement with the overall product strategy and objectives
Provide clinical development input as a member of the IPT Brand Subteam
Manage the creation and maintenance of critical study documents assigned to Clinical Development (e.g., Clinical Study Protocols (CSPs), Investigator’s Brochures (IB), Informed Consent Forms (ICF), Risk-Based Medical Monitoring Plan, Clinical Study Reports (CSRs), and other key regulatory documents) with high quality and consistency with CDP, TPP and AskBio SOPs
Partner with Pharmacovigilance and Safety colleagues to provide continuous evaluation of drug safety profile, including safety monitoring of clinical studies and signal detection from post-marketing surveillance. May serve as a core member of the Safety Management Team (SMT)
Lead the GDNF Clinical Development team during interactions regarding drug development, safety, marketing, regulatory filing, and other aspects of a CNS gene therapy product life cycle
As the neurology medical expert, participate in interactions with external stakeholders (e.g., regulatory authorities, KOLs, Data Monitoring Committee (DMC), advisory boards, patient advocacy groups)
Work collaboratively with Medical Affairs to prepare and present abstracts, manuscripts and presentations for external meetings and publications
May support technical due diligence in Business Development & Licensing (BD&L) activities
Qualification
Required
MD, DO or equivalent (based on the current World Directory of Medical Schools), in addition to Neurology residency training
At least 10 years of clinical development experience in an industry environment spanning Phases I through III/IV
Strong track record and demonstrated excellence in IND/NDA/BLA submissions and approvals
Advanced clinical training, expertise and clinical research experience in a medical/scientific area, preferably with a neurology focus
In-depth knowledge of ICH-GCP, clinical trial design, biostatistics, and regulatory framework for global strategy development
Demonstrated ability to establish strong scientific partnership with internal and external key stakeholders
Demonstrated strong leadership and effective communication skills with a documented record of delivering high quality projects/submissions in a global matrix environment in pharmaceutical or biotech industry or trial conduct in academia or clinical CRO is required
Firsthand experience in organizing and managing scientific or clinical advisory boards
Experience working with Patient Advocacy Groups and other external stakeholders
Demonstrated experience with direct line management; overseeing team performance, fostering professional development, driving clinical development excellence within the organization
Preferred
Advanced knowledge in gene therapy drug development, training or experience in neurosciences with the capability to innovate in clinical development study designs that provide robust clinical evidence to internal decision-makers and regulatory agencies
Movement disorders fellowship training with clinical research experience
Experience with radiographic evaluation of neurologic disease and biomarker development
Company
AskBio Inc.
AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives.
Funding
Current Stage
Late StageTotal Funding
$241.76MKey Investors
Scottish Enterprise
2020-10-26Acquired
2020-09-02Grant· $2.66M
2019-04-11Private Equity· $235M
Recent News
Asklepios BioPharmaceutical, Inc. (AskBio)
2025-10-21
Company data provided by crunchbase